Development of programmable serial blood sampler for infusion clinics, ICUs, clinical trials & medical research. Less waste, risk, labor.
- Stage Product In Development
- Industry Medical Devices and Equipment
- Location West Lafayette, IN, USA
- Currency USD
- Founded September 2007
- Employees 0
Phlebotics has developed a novel medical device that automatically samples small amounts of blood from catheter lines for a broad range of diagnostics or therapeutic purposes (trials, infusion clinics, or ICUs for all ages). The concept has been proven and used many times in the animal market by BASi of West Lafayette, IN. Phlebotics will expand into the human market and has all contractual rights and underlying IP to secure its unique position.
Peter Thomas KissingerChm/CEO
Serial entrepreneur and bioanalytical chemistry academic at Purdue University. Active advisor and board member to diagnostic, medical device and scientific instrument businesses. Private and public firms. Special interests in pharmacology and applications of mass spectrometry, chromatography and electrochemical sensors.
Candice Brenda KissingerFounder; Chief Scientific Officer
Experienced entrepreneur; led team that developed first preclinical automated blood sampler, Culex, and sold globally to pharma/biotech research. Earlier, she first commercialized microdialysis in vivo sampling in USA. Deep international experience.
Has led contract research in preclinical pharmacology and drug metabolism (ADME). Established a translational pharmacology unit at Purdue University.
Nancy LonsingerS&M Advisor
Nancy Lonsinger, Marketing and Sales specialist with a deep background in diabetes monitoring marketing and in supporting healthcare start-up businesses
Joerg SchreiberCOO Advisor
Joerg Schreiber, Ph.D., advising COO, serial entrepreneur with 25 years experience in commercializing medical devices
Dan Boeglin, Faegre Baker DanielsLawyerUnconfirmedJim Schulz, Milestone AdvisorsAccountantUnconfirmed
NIH grant: $1.25 MillionUnconfirmedPete & Candice Kissinger: $400,000Unconfirmed